12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Other News

Watson Laboratories Inc., Alkem Laboratories, Amerigen Pharmaceuticals Ltd., Forest Laboratories, Glenmark, Hetero Drugs, Indchemie Health Specialties Pvt. Ltd.

Forest and Johnson & Johnson's Janssen Pharmaceutica N.V. unit filed suit against Amerigen, Glenmark, Hetero Drugs, Torrent and Watson in the U.S. District Court for the District of Delaware claiming ANDAs for generic versions of hypertension drug Bystolic nebivolol infringe U.S. Patent No. 6,545,040. The patent covers methods...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >